A pharmaceutical composition comprising a combination of nicotinamide and 5-aminosalicylic acid for beneficially affecting the gut microbiota and / or treating gastrointestinal inflammation

摘要

The present invention relates to a novel pharmaceutical composition containing a combination of 5-aminosalicylic acid and nicotinamide or related compounds. This combination is believed to have a beneficial effect on the gut microbiota and / or reduce gastrointestinal inflammation. In certain embodiments, the pharmaceutical composition is partially or fully released into the small or large intestine.